Skip to main content
Signal8

Full Access with Signal8 Pro, $49/mo billed annually.

DataMeds AI Litigation Settlement Extinguishes ~$19 million In Liabilities and Retires 364,099 Common Sharessked

$DVLTPress releaseSep 18, 2026, 6:00 AM ETRead the release

DataMeds AI (NASDAQ: MEDS) settled litigation tied to the May 11, 2023 Wellgistics, LLC Membership Purchase Interest Agreement, wiping approximately $19 million in previously carried liabilities off its balance sheet. Consideration was modest: $450,000 in cash plus retirement of approximately 364,099 common shares -- a deep-discount resolution of the disputed debt and receivables. The tracked ticker DVLT (DataVault AI Inc.) appears only in the forward-looking statements as a counterparty to a proposed multi-party transaction with DataMeds AI alongside Scilex Holding Company, EOS Holdings and HealthBridge Advisors; no direct financial impact on DVLT is stated. Interim Co-CEO Gerald E.

Key figures

Shares retired
364099
Settlement cash paid
450000
Underlying agreement
May 11, 2023 Wellgistics, LLC Membership Purchase Interest Agreement
Liabilities extinguished
19000000

AI analysis

Red flags5 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.

    DVLT: DataMeds AI Litigation Settlement Extinguishes ~$19 million In Liabilities and Retires 364,099 Common Sharessked — AI Analysis | Signal8